These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2005044)

  • 21. Growth deficits in children treated with desipramine: a controlled study.
    Spencer T; Biederman J; Wright V; Danon M
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):235-43. PubMed ID: 1564024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications.
    Varley CK
    Paediatr Drugs; 2001; 3(8):613-27. PubMed ID: 11577926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents.
    Leonard HL; Meyer MC; Swedo SE; Richter D; Hamburger SD; Allen AJ; Rapoport JL; Tucker E
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1460-8. PubMed ID: 8543513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sudden death of a child treated with imipramine. Case study.
    Varley CK
    J Child Adolesc Psychopharmacol; 2000; 10(4):321-5. PubMed ID: 11191693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desipramine in the treatment of children with attention deficit disorder.
    Biederman J; Gastfriend DR; Jellinek MS
    J Clin Psychopharmacol; 1986 Dec; 6(6):359-63. PubMed ID: 3805329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desipramine in the treatment of adolescents with attention deficit disorder.
    Gastfriend DR; Biederman J; Jellinek MS
    Am J Psychiatry; 1984 Jul; 141(7):906-8. PubMed ID: 6375400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute distress after switch from Norpramin to generic desipramine.
    Rosenbaum JF; Falk WE; Gastfriend DR; Gross CC; Pollack MH; Tesar GE; Weilburg JB
    Am J Psychiatry; 1989 Jan; 146(1):122. PubMed ID: 2912233
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of desipramine on autonomic control of the heart.
    Walsh BT; Giardina EG; Sloan RP; Greenhill L; Goldfein J
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):191-7. PubMed ID: 8150790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulant treatment of ADHD and risk of sudden death in children.
    Vitiello B; Towbin K
    Am J Psychiatry; 2009 Sep; 166(9):955-7. PubMed ID: 19528196
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of attention deficit hyperactivity disorder: a critical review.
    Brown CS
    DICP; 1991 Nov; 25(11):1207-13. PubMed ID: 1763538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety of desipramine.
    Werry JS
    J Am Acad Child Adolesc Psychiatry; 1994 May; 33(4):588-91. PubMed ID: 8005913
    [No Abstract]   [Full Text] [Related]  

  • 32. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Coffey B; Geller D; Crawford M; Bearman SK; Tarazi R; Faraone SV
    Arch Gen Psychiatry; 2002 Jul; 59(7):649-56. PubMed ID: 12090818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse effects of switching from fluoxetine to desipramine.
    Van Ameringen M; Mancini C
    Can J Psychiatry; 1992 May; 37(4):278. PubMed ID: 1611591
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and neuropsychological effects of desipramine in children with attention deficit hyperactivity disorder.
    Gualtieri CT; Keenan PA; Chandler M
    J Clin Psychopharmacol; 1991 Jun; 11(3):155-9. PubMed ID: 2066453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms.
    Swanson JR; Jones GR; Krasselt W; Denmark LN; Ratti F
    J Forensic Sci; 1997 Mar; 42(2):335-9. PubMed ID: 9068197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs for attention deficit-hyperactivity disorder do not increase the mid-term risk of sudden death in children: a meta-analysis of observational studies.
    Mazza M; D'Ascenzo F; Davico C; Biondi-Zoccai G; Frati G; Romagnoli E; Bassi B; Janiri L; Moretti C; Gaita F
    Int J Cardiol; 2013 Oct; 168(4):4320-1. PubMed ID: 23669111
    [No Abstract]   [Full Text] [Related]  

  • 37. Sudden (un)explained death.
    Wilens TE; Spencer TJ; Biederman J
    J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1487-8. PubMed ID: 9394927
    [No Abstract]   [Full Text] [Related]  

  • 38. Low dose tricyclic tachycardia.
    Giesler J; Reeve E; Borchardt CM
    J Am Acad Child Adolesc Psychiatry; 1991 Jan; 30(1):151. PubMed ID: 1810269
    [No Abstract]   [Full Text] [Related]  

  • 39. Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
    Spencer T; Biederman J; Kerman K; Steingard R; Wilens T
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):354-60. PubMed ID: 8444765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular effects of desipramine in children and adolescents with attention deficit disorder.
    Biederman J; Gastfriend D; Jellinek MS; Goldblatt A
    J Pediatr; 1985 Jun; 106(6):1017-20. PubMed ID: 3998940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.